BioFocus, a leading provider of gene-toclinical candidate drug discovery services, has been notified by the French Ministry of Higher Education and Research, that its CIR accreditation had been renewed. This will
allow eligible French companies to benefit from significant tax relief (Crédit d’Impôt sur la Recherche) on research carried out by BioFocus on their behalf until 2013. The accreditation is an extension of the current
agreement, in place since 2008, covering work at both UK and The Netherlands research facilities.
“The renewal of our CIR accreditation allows our eligible clients the opportunity to receive 30% of their R&D costs in tax credits,” said Richard Gordon, Senior Director, Sales and Marketing. “Clients who have benefited from
this facility over the last three years can continue to do so and access BioFocus’ evolving discovery platform.”